Literature DB >> 33721188

Albert de la Chapelle-pro memoriam.

Janusz Limon1, Krzysztof Mrózek2.   

Abstract

In this brief article, we celebrate the life and numerous scientific achievements of Dr. Albert de la Chapelle, a pioneer in the fields of human genetics and cytogenetics.

Entities:  

Keywords:  Cytogenetics; Lynch syndrome

Year:  2021        PMID： 33721188     DOI： 10.1007/s13353-021-00625-4

Source DB:  PubMed          Journal:  J Appl Genet        ISSN： 1234-1983            Impact factor:   3.240


  18 in total

1.  8-Trisomy in the bone marrow. Report of two cases.

Authors:  A De la Chapelle; J Schröder; P Vuopio
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

2.  Genetic evidence of X-Y interchange in a human XX male.

Authors:  A de la Chapelle; P A Tippett; G Wetterstrand; D Page
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

Review 3.  Analytic review: nature and origin of males with XX sex chromosomes.

Authors:  A de la Chapelle
Journal:  Am J Hum Genet       Date:  1972-01       Impact factor: 11.025

4.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Hidewaki Nakagawa; Kaisa Sotamaa; Thomas W Prior; Judith Westman; Jenny Panescu; Dan Fix; Janet Lockman; Ilene Comeras; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

5.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

6.  Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia.

Authors:  C D Bloomfield; A Goldman; D Hassfeld; A de la Chapelle
Journal:  Cancer Genet Cytogenet       Date:  1984-03

7.  Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

Authors:  Claudia D Baldus; Sandya Liyanarachchi; Krzysztof Mrózek; Herbert Auer; Stephan M Tanner; Martin Guimond; Amy S Ruppert; Nehad Mohamed; Ramana V Davuluri; Michael A Caligiuri; Clara D Bloomfield; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

8.  Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.

Authors:  Marius Bill; Krzysztof Mrózek; Jessica Kohlschmidt; Ann-Kathrin Eisfeld; Christopher J Walker; Deedra Nicolet; Dimitrios Papaioannou; James S Blachly; Shelley Orwick; Andrew J Carroll; Jonathan E Kolitz; Bayard L Powell; Richard M Stone; Albert de la Chapelle; John C Byrd; Clara D Bloomfield
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

9.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

10.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.

Authors:  Krystian Jazdzewski; Sandya Liyanarachchi; Michal Swierniak; Janusz Pachucki; Matthew D Ringel; Barbara Jarzab; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.